Archive


Category: Byfavo

  • Remimazolam (Byfavo) for Short-Term Procedural Sedation

    Date:  February 21, 2022 Issue #:  1644 Summary:  The FDA has approved remimazolam (Byfavo – Acacia Pharma), an ultra-short-acting IV benzodiazepine, for induction and maintenance of sedation in adults undergoing procedures of up to 30 minutes’ duration.